Main Page
Faculty Deanship
Dean
Health Empowerment Unit
Strategic Planning Unit
Development and Quality Unit
Medical and Bioethics Unit
Vice Dean for Graduate Studies and Research
Vice Dean for Female Section
Vice dean for Academic Affairs
Examination and Assessment Unit
Internship and Alumni Unit
Student Research Unit
E-learning Unit
Student Mentoring and Support Unit
Community Service Unit
Talent and Creativity Care Unit
Continuing Education Unit
Neuroscience Research Unit
Vice Deanship of Clinical Affairs / Administration
Organizational Structure
Departments
Basic Sciences
Department of Anatomy
Department of Pharmacology
Department of Pathology
Department of Microbiology and Medical Parasitolog
Deparment of Clinical Biochemistry
Department of Physiology
Department of Medical Genetics
Clinical Sciences
Department of Otorhinolaryngology
Department of Obstetrics and Gynecology
Department of Hematology
Department of Medical Education
Department of Anesthesia
Department of Family Medicine
Department of Community Medicine
Department of Surgery
Department of Orthopedic Surgery
Department of ophthalmology
Department of Radiology
Department of Internal Medicine
Department of Pediatrics
Department of Emergency Medicine
Department of Urology
Department of Dermatology
Latest News
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Faculty of Medicine
Document Details
Document Type
:
Article In Journal
Document Title
:
Dose escalation phase I study in helthy volunteers to evaluate the safety of a natural product PM701
Dose escalation phase I study in helthy volunteers to evaluate the safety of a natural product PM701
Document Language
:
English
Abstract
:
Abstract: Drug discover from natural sources has played an important role in the treatment of cancer and indeed, most new clinical applications of natural materials over the last half century have been applied to combating cancer. Therefore, this study was directed to describe the safety observations following oral administration of an active ingredient PM701 separated from the camel urine which is a clean, sterile product with antiproliferative activity in experimental tumor bearing animals. The study included 14 healthy volunteers with age between 21-48 years (male and female). They were subjected to full history taking, clinical examination and full laboratory tests including liver and kidney functions hematological parameters (Hb, WBCs and platelet count).The same test were done after oral administration of capsules containing PM701. This fraction has been formulated in gelatin capsule containing 300 mg capsule-1. Systemic reactions of normal volunteers after oral administration of capsules containing PM 701over 28 days revealed no adverse effects on the vital organs. Liver and kidney functions showed no abnormalities. Also, complete blood picture revealed normal pattern before and after PM701 treatment. Two patients only developed hyperacidity which was easily been treated. We may conclude that the product MP701 is safe and may be ready to move to the phase II trials on people who all have the same type of cancer or with several different types of cancer aiming to detect which types of cancer PM701 works for and to get more knowledge about side effects and how to manage them.
ISSN
:
1816-496x
Journal Name
:
Journal of pharmacology and toxicology
Volume
:
5
Issue Number
:
3
Publishing Year
:
2010 AH
2010 AD
Article Type
:
Article
Added Date
:
Tuesday, April 13, 2010
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
عبدالمنعم عثمان
Osman, Abdel-Moneim
Researcher
Doctorate
moneimosman@hotmail.com
Files
File Name
Type
Description
26484.doc
doc
Back To Researches Page